Palvella Therapeutics (PVLA) Non-Current Assets (2013 - 2026)

Palvella Therapeutics (PVLA) has 13 years of Non-Current Assets data on file, last reported at $528000.0 in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $528000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 283.28% YoY), and the FY2025 annual result was $572000.0, changed N/A from the prior year.
• Non-Current Assets declined to $528000.0 in Q1 2026 per PVLA's latest filing, from $572000.0 in the prior quarter.
• Over five years, Non-Current Assets peaked at $25.4 million in Q1 2022 and troughed at $287000.0 in Q3 2023.
• A 4-year average of $15.1 million and a median of $21.1 million in 2023 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets fell 7.81% in 2022, then slumped 98.61% in 2023.
• A 4-year view of Non-Current Assets shows it stood at $22.1 million in 2022, then sank by 98.7% to $287000.0 in 2023, then surged by 99.3% to $572000.0 in 2025, then decreased by 7.69% to $528000.0 in 2026.
• Business Quant data shows PVLA's Non-Current Assets at $528000.0 in Q1 2026, $572000.0 in Q4 2025, and $287000.0 in Q3 2023.